Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,558
Closed -$254K 163
2024
Q4
$254K Buy
+2,558
New +$264K 0.05% 124
2024
Q3
Sell
-7,841
Closed -$971K 123
2024
Q2
$971K Buy
7,841
+1,368
+21% +$176K 0.25% 48
2024
Q1
$854K Buy
6,473
+1,641
+34% +$202K 0.24% 50
2023
Q4
$527K Buy
4,832
+1,056
+28% +$110K 0.17% 49
2023
Q3
$389K Buy
3,776
+2,042
+118% +$220K 0.16% 57
2023
Q2
$200K Buy
+1,734
New +$197K 0.09% 74
2023
Q1
Sell
-1,879
Closed -$208K 66
2022
Q4
$208K Buy
+1,879
New +$192K 0.11% 57

Other funds holding MRK

Unique Wealth's MRK Position: Q1 2025 in Review

Unique Wealth sold out of Merck (MRK) in Q1 2025, closing a stake of 2,558 shares — an estimated $254K sold.

Unique Wealth first reported a position in MRK in Q4 2022 and held it in 7 quarters. The position peaked at $971K in Q2 2024. 3,447 funds tracked by Wall St. Rank hold MRK as of Q1 2025.

  • Unique Wealth reported no remaining Merck position as of Q1 2025 after selling out during the quarter.
  • Unique Wealth sold 2,558 Merck shares in Q1 2025, an estimated $254K.
  • Unique Wealth first reported a position in Merck in Q4 2022 and held it in 7 quarters.
  • Unique Wealth's Merck position peaked at $971K in Q2 2024.
  • 3,447 funds tracked by Wall St. Rank held Merck as of Q1 2025.

Based on Unique Wealth's 13F filing for Q1 2025, filed 11 Apr 2025.